{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001892","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2024-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.131858+00:00","generated_at":"2026-06-07T00:53:39.137061+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bone Biologics regains Nasdaq minimum bid price compliance; stock continues listing","bullets":["Received Nasdaq notice confirming compliance with minimum bid price rule (Rule 5550(a)(2)).","Compliance met on Jan 4, 2024 after 10 consecutive trading days with closing bid price over $1.00.","Stock will continue on Nasdaq Capital Market under discretionary panel monitor until June 28, 2024.","Previously notified of deficiency on Sep 27, 2023 for failing to maintain $1.00 closing bid for 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001892","json":"https://secwatch.observer/filing/0001493152-24-001892.json","markdown":"https://secwatch.observer/filing/0001493152-24-001892.md","text":"https://secwatch.observer/filing/0001493152-24-001892.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224001892/0001493152-24-001892-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224001892/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:53:39.137061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}